All Things Cancer | National Foundation…

Détails du podcast

Informations techniques et générales issues du flux RSS du podcast.

Site

RSS

Apple

Classements récents

Dernières positions dans les classements Apple Podcasts et Spotify.

Liens partagés entre épisodes et podcasts

Liens présents dans les descriptions d'épisodes et autres podcasts les utilisant également.

http://www.youtube.com/@DavidTolkMusic
1 partage

Qualité et score du flux RSS

Évaluation technique de la qualité et de la structure du flux RSS.

Historique des publications

Répartition mensuelle des publications d'épisodes au fil des années.

Derniers épisodes publiés

Liste des épisodes récents, avec titres, durées et descriptions.

He Spent 3 Weeks Unplugged at the Bottom of the Grand Canyon — While Accidentally Revolutionizing Cancer Treatment

Saison 2 · Épisode 3

lundi 11 mai 2026 • Durée 36:03

What happens when a curious biochemist follows his wife to California, falls in love with whitewater rafting — and accidentally makes one of the most important cancer discoveries of the 20th century?

In this episode, we sit down with Dr. Tony Hunter, the 2025 St. Gyorgi Prize winner and Salk Institute legend, whose 1979 discovery of tyrosine phosphorylation laid the foundation for over 80 cancer drugs in use today. We talk about the moment the scientific world accepted his discovery, why America's cancer research dominance is now under serious threat, the "valley of death" killing promising treatments before they reach patients, and what AI can — and can't — do for the future of cancer medicine.

Equal parts science, adventure, and a warning the research world needs to hear.

Lire plusRéduire

Your Mammogram Can Now Predict Cancer Before You Have It -- Here's the Doctor Making It Happen

Saison 2 · Épisode 2

jeudi 9 avril 2026 • Durée 26:10

What if you could know your breast cancer risk at 25 and actually do something about it?

Dr. Funmi Olopade, a trailblazing oncologist at the University of Chicago, has spent 30 years rewriting the rules of breast cancer care, and she believes we can eradicate it as a cause of premature death within a decade.

In this episode, she breaks down how AI, genetic testing, and a simple blood test are transforming early detection, why too many women are still being failed by a broken system, and what every woman should be doing right now, no matter their age.

This is a conversation that could change how you think about your own health.

Lire plusRéduire

Doctors Gave Her 3 Years to Live. She Changed Cancer Research Instead.

Saison 2 · Épisode 1

vendredi 6 mars 2026 • Durée 01:01:27

At age 37, Kathy Giusti was diagnosed with multiple myeloma and told she had just three years to live. Instead of accepting that fate, she turned urgency into action and founded the Multiple Myeloma Research Foundation (MMRF), transforming how cancer nonprofits accelerate drug development. Today, more than 15 therapies have been approved for multiple myeloma and survival rates have more than doubled.

In this episode of All Things Cancer, Dr. Sujuan Ba speaks with Kathy Giusti about her new book Fatal to Fearless, the leadership and strategy required to drive progress in cancer research, and how collaboration between nonprofits, academia, industry, and regulators can speed lifesaving treatments to patients.

They also explore the future of cancer research, including venture philanthropy, data sharing, AI-driven discovery, and why patients must be empowered to advocate for themselves in a complex medical system.

Lire plusRéduire

Why Was Half This Village Dying of Cancer— And No One Stopped It?

Saison 1 · Épisode 16

mardi 17 février 2026 • Durée 39:24

Half a village was dying of cancer. No one could explain why.

For the Season One finale of All Things Cancer, we’re ending with a story that changed the trajectory of cancer research — and saved generations of lives.

What began as a keynote trip to Turkey turned into one of the most extraordinary cancer investigations in modern medicine.

In this episode, Dr. Michele Carbone shares how he uncovered a deadly inherited mutation, confronted government officials, helped relocate entire villages, and identified the BAP1 gene — a discovery that transformed our understanding of mesothelioma and inherited cancer risk.

But the twists don’t stop there.

After four years, $10 million in funding, and zero published results, his research was on the brink of collapse. Then a 1-in-100-billion clue changed everything.

In this episode, you’ll hear:

How a remote village in Turkey led to a global cancer breakthrough
The gene that can guarantee cancer — yet may also help patients survive it
The policy battle that protected future generations
Why Dr. Carbone warns against overreliance on AI in medicine
And how cooking helped him build a cancer center from the ground up

This is a story about persistence, courage, and the power of research to move beyond the lab and into real lives.

As we close out Season One, this conversation is a powerful reminder of why cancer research matters — and what’s possible when science meets compassion.

Lire plusRéduire

We’re Drowning in Cancer Data — And Still Missing Cures

Saison 1 · Épisode 15

mardi 27 janvier 2026 • Durée 01:01:17

In this episode, Dr. Sujuan Ba is joined by Dr. Ann Barker, one of the most influential architects of modern cancer research, for a wide-ranging conversation on where the field is headed and what must change to accelerate progress.

Dr. Barker shares why cancer research is at a critical inflection point, driven by an explosion of data, the rise of artificial intelligence, and the urgent need to move beyond siloed science. Together, they explore the promise and limitations of AI in oncology, the importance of high-quality and standardized data, and why collaboration across disciplines is no longer optional.

The conversation also dives into funding challenges, the role of nonprofits in building shared research infrastructure, and how convergence science has powered landmark efforts like The Cancer Genome Atlas and GBM AGILE. Dr. Barker reflects on her career, the lessons learned from large-scale collaboration, and why this moment may be one of the most exciting in the history of biomedical research.

This episode offers a candid, big-picture look at how AI, data, and collaboration could shape the future of cancer research — and what it will take to get there.

Lire plusRéduire

One Diagnosis. Seven Years. A Lifetime of Impact.

Saison 1 · Épisode 14

vendredi 12 décembre 2025 • Durée 31:03

In this heartfelt episode of All Things Cancer, NFCR CEO Dr. Sujuan Ba sits down with Shereen Pavlides and her daughter, Isabella Pavlides, to explore how personal loss can spark powerful action.

From Isabella’s leadership through Play4TheCure and her growing Dine & Donate initiative to the lasting influence of her grandmother Esther’s seven-year journey with pancreatic cancer, this conversation highlights caregiving, resilience, and the next generation of advocates stepping up for cancer research.

It’s a moving reminder of how community, compassion, and initiative help make cures possible.

Lire plusRéduire

Cancer Research Is at Risk: Dr. Bertagnolli Reveals What Washington Isn’t Saying

Saison 1 · Épisode 13

mardi 25 novembre 2025 • Durée 50:28

In this episode of All Things Cancer, Dr. Sujuan Ba sits down with Dr. Monica Bertagnolli — surgeon, scientist, former Director of the National Cancer Institute and former Director of the National Institutes of Health — for one of the most candid and forward-looking conversations we've ever shared.

Dr. Bertagnolli reflects on her journey from a cattle ranch in rural Wyoming to leading the nation’s most important scientific institutions, the challenges facing today’s cancer research ecosystem, the impact of declining federal funding, and what it will take to protect the future of discovery. She also offers a clear-eyed look at artificial intelligence, the trust required to use it in patient care, and the national learning health system we must build to ensure every community benefits.

A compelling conversation about leadership, equity, scientific progress, and the urgent need to support cancer research.

Lire plusRéduire

The Next Frontier: Can CAR-T Therapy Finally Conquer Solid Tumors?

Saison 1 · Épisode 12

lundi 27 octobre 2025 • Durée 28:31

What happens when a pioneering oncologist and a next-generation immunotherapy researcher sit down to talk about the future of cancer care?

Join NFCR President and CEO Dr. Sujuan Ba as she moderates an eye-opening discussion between Dr. Brian Leyland-Jones and Dr. Avery Posey. From early detection and sequencing to CRISPR and CAR-T breakthroughs, this episode dives into the science — and the human drive — behind making cures possible.

Lire plusRéduire

Beyond the Tumor: Dr. Isaac Witz’s Vision for the Future of Cancer Treatment

Saison 1 · Épisode 11

mercredi 1 octobre 2025 • Durée 20:18

In this episode of All Things Cancer, NFCR CEO Dr. Sujuan Ba sits down with Dr. Isaac Witz, the 2023 Szent-Györgyi Prize for Progress in Cancer Research laureate and a pioneer in tumor microenvironment science. Decades before it became a central focus of oncology, Dr. Witz recognized that cancer is not just about tumor cells—it’s about the environment that surrounds them.

Dr. Witz shares how he challenged conventional thinking, why keeping patients at the center of research matters, and how his discoveries reshaped cancer treatment worldwide. From immune responses inside tumors to overlooked “orphan results” and the role of collaboration, this conversation explores both the groundbreaking past and the future of holistic, patient-driven cancer research.

Listeners will hear Dr. Witz’s insights on:

The origins of tumor microenvironment research.
Why therapies must go beyond targeting cancer cells.
The importance of integrating overlooked discoveries into clinical progress.
His vision for AI and international collaboration in advancing cures.

Lire plusRéduire

From Aha Moments to Breakthroughs: Dr. Drew Pardoll on Immunotherapy

Saison 1 · Épisode 10

lundi 8 septembre 2025 • Durée 38:38

In this episode of All Things Cancer, NFCR President and CEO Dr. Sujuan Ba sits down with Dr. Drew Pardoll, a pioneer in cancer immunology, to explore the breakthroughs reshaping cancer research. From harnessing the immune system and advancing protein, cell, and microbial engineering to launching biotech startups that translate discoveries into real treatments, Dr. Pardoll shares how innovation and collaboration are driving cures forward. Together, they also reflect on the vital role of young scientists, the importance of smarter clinical trials, and what’s next on the horizon for cancer patients worldwide.

Lire plusRéduire

Podcasts et contenus similaires

Autres podcasts ou contenus associés partageant des thèmes ou audiences similaires.

All Things Cancer | National Foundation for Cancer Research – Détails, épisodes et analyse

Détails du podcast

Classements récents

Apple Podcasts

Spotify

Liens partagés entre épisodes et podcasts

Qualité et score du flux RSS

Historique des publications

Derniers épisodes publiés

Podcasts Similaires Basées sur le Contenu

Podcasts Similaires Basées sur le Contenu

Apple Podcasts

Spotify

All Things Cancer | National Foundation for Cancer Research – Détails, épisodes et analyse

Détails du podcast

Classements récents

Apple Podcasts

Spotify

Liens partagés entre épisodes et podcasts

YouTube1

Qualité et score du flux RSS

Historique des publications

Derniers épisodes publiés

Podcasts et contenus similaires

Podcasts Similaires Basées sur le Contenu

Podcasts Similaires Basées sur le Contenu

YouTube1

Apple Podcasts

Spotify